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The mission of the annual Cornell Leadership Program 
for Veterinary Students is to provide students with 
learning experiences that clarify and reinforce their 
commitment to careers in science. The Program is 
distinguished by a tradition of excellence that spans 24 
years. During this time, 562 alumni have participated. 
These individuals came from 67 veterinary colleges 
in all parts of the world and many, as we had hoped, 
have become scientifi c leaders within the veterinary 
profession. We are happy to report that 22 outstanding 
scholars participated in this year’s program. Already 
some of these scholars have committed to a career 
that will involve research. It is too early to know where 
they will take their careers; however, based on the 
outstanding achievements of past participants we 
expect great things from them.
Research is the major focus of the Leadership Program. 
Program scholars pursue individual research projects 
under the mentorship of Cornell faculty members who 
are all highly successful scientists and experienced 
mentors. The University’s world-class research facilities 
and unsurpassed intellectual environment support 
the scholars’ research investigations. In addition to 
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participate in modules and workshops that are designed 
to highlight employment and leadership opportunities 
for veterinary graduates in academia, government, and 
industry.
Biomedical research focuses on the mechanisms 
underlying disease and uses this information to devise 
new therapies. It is critical for the long-term success of 
the veterinary profession that veterinarians engage in 
biomedical research and yet there is currently a shortage 
of veterinarians entering such careers. Veterinary 
students often have a detailed understanding of what 
a career in clinical medicine will entail, but are much 
less informed about careers in biomedical research, 
public health, or in the pharmaceutical industry. Most 
students enter veterinary school with a clinical practice 
career in mind. Our goal is to show the most talented 
of our veterinary students the attractions of biomedical 
research and to provide them with detailed practical 
career guidance on how to succeed and prosper as 
veterinary research scientists. 
One of the pleasures of organizing this program is 
hearing about the career achievements of our alumni. 
Their experiences provide valuable insight into problems 
facing veterinarians in research careers. Issues such 
as student debt and shrinking budgets for research are 
important factors that infl uence career choices. As new 
challenges arise, we expect to provide practical guidance 






The Leadership Program for Veterinary Students is 
made possible through awards from federal agencies, 
corporations, foundations, and other private sector 
sponsors. For their generous support this year, the 
program organizers thank:
Albert C. Bostwick Foundation
Boeringer-Ingelheim Co. 




The program organizers also thank the facilitators, 
counselors, and mentors who took part in the 2013 
program. Thank you to Ms. Emily Zerishnek, the Program 
Coordinator, Ms. Jennifer Best, Ms. Alexis Wenski-
Roberts, and Mr. David Frank for their assistance. 
Finally, the organizers congratulate the participating 
scholars. Their academic achievements, coupled with 
their dedication to discovery and service, mark these 
individuals as future leaders of the veterinary profession
From time-to-time, the program organizers and their 
associates have described elements of the program, 
strategies for their implementation, and outcomes of this 
initiative. Recent publications include: 
• Promoting Science-Based Careers Through Student-
Directed Learning. McGregor, D.D. and Fraser, D.R. J. 
Vet. Med. Educ. 33; 294, 2006.
• Counseling Veterinary Students Who Aspire to 
Careers in Science. McGregor, D.D. and Fraser, D.R. 
JAVMA 229:668, 2006.
• Acquainting Veterinary Students With Careers in the 
Pharmaceutical Industry. McGregor, D.D., Fraser, 
D.R., Haven, M.L. and Hickey, Gerard. J Vet. Med. 
Educ. 34:139, 2007. 
• Career Paths of Alumni of the Cornell Leadership 
Program for Veterinary Students. Fraser, D.R., 
McGregor, D.D. and Gröhn, Y.T. Vet. Record 163:750, 
2008.
Interested parties also are invited to visit the program 
website at http://www.vet.cornell.edu/oge/leadership
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2013 Leadership Program Agenda
Monday, June 3  Opening Meeting and Ethics Discussion
    Biological & Chemical Safety Training
    Welcome BBQ
Tuesday, June 4  Library Orientation 
    Laboratory Orientation
Saturday, June 8  Career Discussion
Monday, June 10  Leadership Module
    Reception & Dinner
Thursday, June 13  National Institutes of Health 
Friday, June 14   Walter Reed Army Institute of Research & 
Wednesday, June 19  Reunion Dinner
Tuesday, June 25  Research Project Previews
Thursday, June 27  Hypothesis Development Workshop Pre-Meeting
Tuesday, July 2   Drug Design and Development Workshop
Monday, July 8   Infectious Diseases Workshop
Monday, July 15  Research Training
Tuesday, July 16  Leadership in Action 
Thursday, July 18  Hypothesis Development Workshop
Monday, July 22  Careers in Industry Workshop
Thursday, July 25  Translational Science
Monday, July 29  Career Planning
Wednesday, July 31  Wine and Cheese Event
Wednesday, August 7  Research Presentations
Thursday, August 8  Research Presentations
    Farewell Dinner
Friday, August 9  Exit Breakfast
Naval Medical Research Center
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Name  University  Mentor(s)  Department  Sponsor
 
Helena Brewer University of Edinburgh Avery August  Microbiology/Immunology Wellcome Trust
Casey Cazer Cornell University  Yrjö Gröhn  VM Administration  Zoetis
Frances Chen Cornell University  Natasza Kurpios  Molecular Medicine Zoetis & Bostwick
Iva Cvitaš University of Zagreb Scott Coonrod  Baker Institute  Zoetis & Bostwick
Hannah Eastwood University of Bristol Brian Kirby  Mechanical &   Wellcome Trust
            Aerospace Engineering
Carrie Fischer University of Calgary Douglas Antczak  Baker Institute  Zoetis
Angus Fisk University of Queensland Nozomi Nishimura  Biomedical Engineering Zoetis
Krystana-Elisa Föh Freie Universität Berlin Brian Rudd  Microbiology/Immunology Bostwick
Lucy Hardwick University of Liverpool Yrjö Gröhn  VM Administration  Wellcome Trust
Lauren Healy Cornell University  Matt DeLisa  Chemical Biology  Zoetis
Aimée Heinz Freie Universität Berlin David Lin   Biomedical Sciences Bostwick
Silvia Janska Royal Veterinary College Gerlinde Van de Walle Baker Institute  Wellcome Trust
Nandita Kataria University of Sydney Robert Weiss  Biomedical Sciences Zoetis & Bostwick
Wilfred Leung University of Queensland Holger Sondermann Molecular Medicine Zoetis & Bostwick
Jenny Munhofen University of Georgia Ted Clark   Microbiology/Immunology Zoetis
Tessa Procter Bristol University  Douglas Antczak  Baker Institute  Wellcome Trust
Marieke Ravenek Utrecht University  Kenny Simpson  Clinical Sciences  Zoetis
Hendrik Sake TiHO Hannover  Gary Whittaker  Microbiology/Immunology DAAD, Boehringer-Ingelheim & Feline   
           Health Center
Neharika Saxena Rajasthan University Craig Altier  Population Medicine/  Zoetis & Bostwick
            Diagnostic Sciences
Svenja Wiechert TiHO Hannover  Tracy Stokol  Population Medicine/  DAAD, Boehringer-Ingelheim & Bostwick
            Diagnostic Sciences
Stefanie Witte TiHO Hannover  Rick Cerione/Marc Antonyak Molecular Medicine DAAD, Boehringer-Ingelheim & Bostwick
Bosco Yeung Royal Veterinary College Nozomi Nishimura  Biomedical Engineering Wellcome Trust
2013 Leadership Program Scholars
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The Leadership Program combines faculty-guided research with student-directed 
learning through participation in modules, workshops, and group discussions. The 
activities encourage responsible leadership, critical thinking, and the development 
of teamwork skills. The program also highlights graduate training opportunities 
calculated to promote the professional development of program alumni as 
independent scientists and public health professionals.  
Research
Each Leadership Program scholar is assigned a project and a faculty mentor to guide his or her research. The 
projects enable the students to gain practical experience by exploring problems of interest to them. Simultaneously, 
students hone their communication skills through engagement in group discussions and by presenting their 
research fi ndings in a public forum at the conclusion of the program.
Activities 2013
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Leadership 
Leadership and its attendant responsibilities are central considerations in the Leadership Program. Critical thinking 
and decision-making are featured in a scenario-based module that explores public health, economic, political, 
and social issues. Students and facilitators are assigned roles that oblige them to articulate, defend, or modify 
their views as the scenario unfolds. At the conclusion of the module, the facilitators comment on the exercise and 
discuss leadership principles they have adopted in their own careers. This year, Professor David Fraser moderated 
the discussion with assistance from Professor Gerhard Breves, Professor Douglas McGregor, Vice Provost Judith 
Appleton, and Associate Dean Susan Tornquist. 
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Leadership in Action
The fi lm entitled, “A Few Good Men” illustrates strengths 
and defi ciencies of individuals cast in the role of leaders. 
The students discussed leadership characteristics 
illustrated by the fi lm. Professors David Fraser, Douglas 
McGregor, and Drew Noden offered points to consider as 
well as feedback for the students to ponder.    
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Infectious Diseases 
A workshop moderated by Professors Terence Dermody, 
Philip Carter, John Parker, Alfonso Torres, and Robin 
Yates featured discussions of antibiotic resistance and 
diseases which are emerging or re-emerging in nature or 
which pose a bioterrorist threat to people or the Nation’s 
agricultural assets. Program scholars selected the 
diseases on which they wanted to focus on. Then they 
conducted library research on the topics, and employed 
Socratic methods to engage their peers and facilitators 
in lively and informative discussions.  Later in the day, 
the facilitators commented on related issues and the 
need for veterinary scientists who contemplate careers 




Dr. Michelle Haven, a senior executive of Zoetis Inc., 
designed and moderated a competition between mock 
companies formed by the students. The competition 
encouraged creativity and the development of 
teamwork skills through activities connected with the 
discovery, development and marketing of veterinary 
pharmaceuticals. Drs. Sallie Cosgrove and Christopher 
Maitland assisted Dr. Haven in this module. Later in 
the evening, the three facilitators answered questions 
regarding the range of employment opportunities for 
veterinarians at Zoetis Inc. and the advanced training 
required to be competitive for such positions.
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Careers in Industry
Drs. Gerard Hickey, Emily Hickey, and Peggy McCann 
conducted mock interviews for three positions in the 
pharmaceutical industry and at Merck & Co. in particular. 
The students prepared for the interviews by reviewing 
the resumes of prospective applicants and by submitting 
application letters for the positions. On the day of the 
meeting, the facilitators commented on the letters and 
posed questions to the students that explored their 
personal interests and qualifi cations for employment.   
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Hypothesis Development
Veterinary students have a strong desire to work on 
problems of importance to human and animal disease. 
To encourage students to actively think about how 
hypothesis-driven research might benefi t animals, the 
students prepared ‘blue-sky’ hypothesis-driven research 
proposals focused on the problem of multidrug-resistant 
tuberculosis. Facilitators, Drs. David Russell and Brian 
VanderVen, then reviewed the proposals and made 
suggestions before the students presented their ideas to 
the group and heard feedback from the facilitators.
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Career Explorations
Career planning is featured prominently in the 
Leadership Program. Three meetings were convened 
to consider opportunities for veterinary graduates to 
broadly infl uence the veterinary profession through 
careers in the academy, government or industry. 
Professor David Fraser and Dr. Jenny Sones reviewed 
career options available to veterinary graduates who 
aspire to careers in science. The two counselors 
emphasized the importance of selecting a superior 
environment for graduate research training and a mentor 
who has a successful training record.  
A companion meeting addressed issues related to 
graduate research training. Professors Robert Weiss and 
Douglas McGregor identifi ed aspects of training that 
one should weigh in selecting an institution for graduate 
study; the subject of one’s thesis research and an 
individual to guide one’s graduate studies. 
In a separate meeting, a case study illustrated 
“translational science.” The ensuing discussion led by 
Professor Kenneth Simpson revealed how an individual 
trained to a high level of profi ciency as both a clinical 
specialist and research scientist can extend the frontiers 
of knowledge through his or her capacity to defi ne 
disease mechanisms at the cell or molecular level. 
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The National Institutes of Health and the Cornell 
University College of Veterinary Medicine have 
forged a partnership that offers program scholars an 
opportunity to learn about research conducted at the 
nation’s premier biomedical research institution. This 
year’s participants gathered on the main campus of 
the NIH for a full day of scientifi c presentations and 
discussions. Speakers included distinguished scientists 
and administrators drawn from the agency’s intramural 
research program
NIH
Cornell’s Partnership with the National Institutes of Health
19To prepare tomorrow’s scientists and public health professionals
Agenda 
Welcome and Introduction
Dr. Richard Wyatt, M.D.
Executive Director, Offi ce of Intramural Research
“Ovarian Cancer Susceptibility Genes in Zebrafi sh”
Dr. Heather Shive, D.V.M., Ph.D.
Staff Scientist, Experimental Transplantation & 
Immunology Branch, NCI
“Dynamics of immunity to infection and tissue injury”
Dr. Dorian McGavern, Ph.D.
Senior Investigator, Viral Immunology & Intravital 
Imaging Section, NINDS 
“Preclinical Animal Studies Review at FDA Center for 
Devices”
Dr. Victoria Hampshire, V.M.D.
 Director of Device Review, FDA
“The Road Less Traveled – Veterinary Scientists 
Engaging in Research”
Dr. Franziska Grieder, D.V.M., Ph.D.
Associate Director, Division of Comparative 
Medicine, NIH
“Research Training Opportunities at NIH and 
Comparative Melanoma in Dogs and Humans: 
Validating a Naturally Occurring Preclinical Model”
Dr. Mark Simpson, D.V.M., Ph.D.
Head, Molecular Pathology Unit, Director, NIH 
Comparative Biomedical Scientist Training Program, 
Lab of Cancer Biology and Genetics, NCI
“Base Pairs to Body Plan: How Bad Genes in Good 
Dogs Aid Human Health”
Dr. Elaine Ostrander, Ph.D.
Senior Investigator, Cancer Genetics Branch, NHGRI
“Exploring the Mechanism and Signifi cance of Cell 
Type-Dependent Neutralization of Flaviviruses”
Dr. Ted Pierson, Ph.D.
Senior Investigator, Chief, Viral Pathogenesis 
Section, Laboratory of Viral Diseases, NIAID
“Examining the Immune Mechanisms of Adenovector-
based Vaccine-induced Ebola Protection”
Dr. Annie Kilby, Ph.D.
Research Fellow, Sullivan Lab, Biodefense Research 
Section, Vaccine Research Center, NIAID
Closing Remarks
Dr. John S. L. Parker
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Armed Services & Infectious 
Disease
Leadership Program scholars had the privilege this 
year of visiting the combined facilities of the Walter 
Reed Army Institute of Research (WRAIR) and the 
Naval Medical Research Center (NMRC). The visit was 
organized and coordinated by Dr. (LTC) Ken Despain, 
Director, Veterinary Services Division. Senior members 
of the combined center staff described the remarkable 
progress being made at the facility in addressing still 
unresolved problems of infectious diseases, which are of 
special concern to the uniformed services. The scientifi c 
program was followed by a short tour of the superb 




CAPT John Sanders, Commanding Offi cer NMRC
COL Shanda Zugner, Executive Offi cer WRAIR
Blast Overpressure Medical Countermeasures
Dr. Joseph Long, Chief of Blast Induced Neurotrauma 
Branch
Discussion/Questions/Blast Tube Demonstration
Undersea Medicine Research at NMRC
Dr. Aaron Hall, Undersea Medicine
Lt Ryan Sheppard, Undersea Medicine
Discussion/Questions/Tour of Dive Chambers
Malaria Treatment and Prevention
 LTC Lisa Read, Experimental Therapeutics
Discussion/Questions/Tour of Insectary
Army Institute of Research/
Naval Medical Research Center
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Leadership Program scholars discussed their research in 
a series of presentations over two days at the conclusion 
of the program. A book prize was awarded to Helena 
Brewer for the best overall research achievement as 
judged by her underlying hypothesis, investigative 
protocol, results, and presentation. Additional prizes 
were awarded to Carrie Fischer, Aimée Heinz, and 
Stefanie Witte, for exceptional achievements in 
integrative biology, cell biology, and molecular biology, 
respectively. Wilfred Leung was awarded a prize for 
the highest-ranking presentation by a scholar from the 
United Kingdom or Australia. The Selection Committee 
for the 2013 Leadership Program salutes these 
individuals and congratulates the entire group for their 
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function in Epilepsy with 








Microvesicles: A new form of 
Stem Cell Communication
Presentations & Prizes
UK & Australia Prize
Wilfred Leung
Investigating biofi lm formation 
in bacteriaInvestigating biofi lm 
formation in bacteria
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Helena Brewer, University of Edinburgh, Immunology
Exploring the role of CD8 cells in Hypersensitivity Pneumonitis
During my intercalated degree year I was exposed to the world of veterinary 
research. The experience was enjoyable and encouraged me to learn more about 
research career opportunities for veterinarians. Prior to the program, I hadn’t 
considered working with laboratory animals so I was interested to learn that I 
would be conducting research on a murine model of a pulmonary disease, under 
the mentorship of Professor Avery August. My project aimed to determine how CD8 
lymphocytes infl uence the disease process in hypersensitivity pneumonitis – a 
Th17 mediated disease.
I had the opportunity to learn more about mouse models by completing lab animal 
training and performing experiments on genetically-manipulated Vertex mice. 
The latter lend themselves to measurement of interleukin 10, an infl ammatory 
lymphokine. I became familiar with laboratory techniques such as fl ow cytometry in 
order to measure intracytoplasmic cytokine levels in cells obtained by lung lavage. 
In addition, I ascertained the severity of disease by conventional microscopy. 
My experimental results indicate that mice defi cient in CD8 cells have a higher proportion of CD4 cells that express 
IL-10. Histopathology revealed the area of granulomatous infl ammation was reduced in CD8-depleted mice. 
Experiments still to be done will further defi ne the role of CD8 cells in this disease.
I would like to thank the members of August lab, especially Sonia Mohinta, for all their assistance this summer and 











Casey Cazer, Cornell University, Population Medicine and Epidemiology
Assessing antimicrobial pressure on enteric commensal bacteria of beef cattle fed 
chlortetracycline for growth promotion, metaphylaxis, or disease treatment
When I fi rst dreamed of becoming a veterinarian, I envisioned myself directly 
helping animals of all kinds—diagnosing their ills and treating them. But my 
research experience in veterinary school shifted my trajectory towards pursuing 
research. I applied for the Leadership Program hoping for insight into my potential 
career directions.
In the Leadership Program I researched the effects of antimicrobial usage on 
antimicrobial-resistant E. coli in feedlot cattle. These bacteria can enter the food 
chain and transfer resistance genes to human enteric commensal and pathogenic 
bacteria. I built a systems dynamics model to determine the concentration of 
chlortetracycline, a common antimicrobial used on feedlots, in the large intestine 
where E. coli live. We found that with growth-promoting doses of chlortetracycline, 
the large intestine concentration is below the E. coli minimal inhibitory 
concentration (MIC), but there could still be selective pressure on enteric bacteria 
through sub-MIC effects. However, the disease-treatment dose created above-
MIC selective pressure. Hence, a decreased use of antimicrobials for growth promotion may increase the selective 
pressure on enteric bacteria by increasing the incidence of animal disease. My pharmacokinetic model will be used 
to investigate the changes in genotype of tetracycline-resistant E. coli in feedlot steers treated with chlortetracycline.
I found that the Leadership Program provided me with important information regarding career opportunities for 
veterinarians in research fi elds, which will help me make informed decisions to shape my career. I would especially 
like to thank Dr. Gröhn for his mentorship and support of my research, Dr. Parker for his advice and insights and 
Zoetis Inc. for providing fi nancial support.
Frances Chen, Cornell University College of Veterinary Medicine, Genomics, 
Genetics, and Development
Chromatin level regulation of organ morphogenesis: differential methylation at 
the evolutionarily conserved Pitx2 locus may drive asymmetric Pitx2 expression 
essential to organogenesis
In the developing embryo, the establishment of left-right (L-R) asymmetry by the 
transcription factor Pitx2 is crucial for proper organ form and function in the 
adult. Differential expression of Pitx2 across the L-R axis provides directionality 
in heart looping, gut rotation, and other aspects of asymmetric organogenesis. 
I spent this summer continuing my work in the Kurpios Lab studying how the 
regulatory mechanisms of the genome inherent in chromatin structure can 
orchestrate cellular identity and behavior by precisely directing spatiotemporal 
gene transcription. 
My project aimed to ask how differential methylation at the Pitx2 locus could be 
playing a role in asymmetric Pitx2 expression and therefore in left-right asymmetric 
organogenesis. DNA methylation is a key epigenetic mechanism for regulating 
gene transcription and is vital for a number of developmental processes. From 
previous data that I helped to generate, we proposed a model in which genomic regulatory elements interact to 
differentially organize chromatin in left vs right nuclei, ultimately driving the binary, asymmetric expression of Pitx2 
during L-R organogenesis. By performing bisulfi te sequencing on microdissected samples of left and right embryonic 
chicken tissue, I gathered preliminary data that suggests differential methylation patterns may exist between the left 
vs. right cells of the developing chicken gut. Ultimately, this work will provide further evidence that the organization 
of the Pitx2 genomic locus is integral in regulating differential Pitx2 expression in L-R organogenesis. 
I would like to thank Zoetis Inc. and the Bostwick Foundation for supporting me during the program.
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Iva Cvitaš, University of Zagreb, Croatia, Molecular Biology 
Peptidylarginine deiminase-2 overexpression in transgenic mice leads to an 
increase in premalignant skin lesions
From the age of fi ve I have been obsessed with the idea of helping animals and 
humans. That is why in 2009 I began my studies of veterinary medicine at the 
University of Zagreb. My curiosity and enthusiasm coupled with my experience 
working with an inspirational professor kindled my interest in biomedical 
research. I applied to the Cornell Leadership Program in the expectation of 
gaining experience in research, expanding my knowledge of cancer biology, and 
exploring different career possibilities.
This summer I had the pleasure of working in the Coonrod lab which focuses 
on the role of Peptidylarginine deiminase (PAD) enzymes  in cancer biology, 
and  especially PAD2  in mammary tumor progression. My project involved an 
investigation in transgenic mice that overexpress PAD2. More than 20% of such 
mice develop precancerous skin lesions. My task was to determine the tissue 
distribution of PAD2. In the course of the summer, I found that PAD2 expression 
is high not only in the mammary tissue of such mice, but also in the uterus, colon 
and salivary glands. 
 I am truly grateful to the organizers of the Program for selecting me, and to the Coonrod lab for providing excellent 
mentorship and a very interesting project. I am especially grateful to Sachi Horibata for being a great teacher and an 
amazing friend. Finally, I want to thank Zoetis Inc. and the Bostwick Foundation for funding my program scholarship.
Hannah Eastwood, University of Bristol, Biomedical Engineering 
Novel investigations into ex- vivo Culture of Circulating Tumour Cells
When initially presented with the Cornell Veterinary Leadership Program, I could 
see this was an opportunity not to be missed in gaining fi rst-hand experience to 
explore research career options. The ten week experience has far exceeded my 
expectations, exposing me not only to a variety of career paths, but also introducing 
me to a truly supportive network of colleagues.    
I had the opportunity to work in Brian Kirby’s Micro/Nanofl uidics Laboratory, in 
the Sibley School of Mechanical and Aerospace Engineering. I worked upon a 
proof of concept – that culturing cells in alginate (a polysaccharide) would allow 
the ex vivo growth of neoplastic cells. I also looked into the hypothesis that micro-
vesicles shed from other neoplastic cells would accelerate and alter a secondary 
cancerous growth. The results of my research showed that micro-vesicles appear to 
be successful in promoting cell growth but growing cells in alginate proved to be a 
problem. Although the cells remained alive in alginate, they failed to replicate. This 
is the next step to be solved by the Kirby Laboratory.
This summer at Cornell has been unforgettable. I would like to thank the Wellcome Trust for funding this amazing 
opportunity, I am truly grateful for the insight to laboratory work and research skills that Dr. Kirby and his laboratory 
members gave me. I am especially grateful to my supervising PhD student, Steven Santanna, who guided me 
throughout the program. Finally, I am indebted to the program facilitators for selecting me and enlightening my 
career opportunities in the midst such dynamic and inspirational colleagues. They will be powerful allies in whatever 
I do in my future career.
 
26 www.vet.cornell.edu/oge/leadership
Carrie Fischer, University of Calgary, Immunology
Investigating the demise of the endometrial cups
I have always had a passion for research. Prior to starting my DVM, I completed 
a PhD in the fi eld of mucosal infl ammation and innate immunity. Participating in 
the Cornell Leadership Program introduced me to numerous veterinary career 
options, exciting areas of research, and gave me the opportunity to work alongside 
inspirational scientists and highly motivated students. Most importantly, this 
program solidifi ed my desire to pursue a research-based career in veterinary 
medicine.
It was simply a privilege to work in Dr. Doug Antczak’s laboratory. My project 
focused on investigating the lifespan of endometrial cups and determining 
whether trophoblasts succumb to an apoptotic death. Given the limited 
number of apoptosis-related studies in the horse, I fi rst optimized fl uorometric 
and colorimetric assays and antibodies in equine in vitro and ex vivo cellular 
preparations.  I then looked for characteristic features of apoptosis in frozen 
endometrial cup tissue and biopsies of chorionic girdle trophoblasts that had 
been transplanted into SCID mice. DNA fragmentation, active Caspase-3, and 
PARP cleavage could not be detected in trophoblasts at days 54, 64, 74, 84, and 149 post-ovulation. Findings from 
this study suggest that the demise of the endometrial cups may be due to another mechanism that has yet to be 
elucidated. 
Many thanks Dr. Antczak for being a wonderful, thought-provoking mentor, as well as all the members of the Antczak 
lab and Baker colleagues. I am particularly grateful for having worked alongside Becky Harman, and thank her 
immensely for her assistance and encouragement this summer. I would also like to thank Zoetis Inc. for funding my 
summer research project.
Angus Fisk, University of Queensland, Biomedical Engineering
Lighting up signaling in the brain: optical recording of neural activity
I am grateful for this fantastic experience to reach out from my clinical studies 
to participate in basic science, learning about how we advance science and 
knowledge.
Single neurons fi ring are well studied; however we know less about how neuronal 
populations fi ring in synchronized patterns generate motion, sensation, and 
behavior. My project explored methods for imaging neural fi ring via transient 
changes in intracellular calcium concentrations, hoping to interpret patterns in 
large neuronal populations. The ultimate aim is to develop novel optical methods 
of recording neural activity for brain-machine interfaces that could be used to 
control prosthetics such as artifi cial limbs. We imaged in vivo neural activity in 
rodent brains with multi-photon microscopy, using calcium sensitive-dyes that 
alter their fl uorescence when action potentials increase intracellular calcium. We 
recorded single cells in the somatosensory cortex of anaesthetized animals. To 
interpret neural activity for brain-machine interfaces, we need to link activity to its 
effects; therefore we imaged the motor cortex in awake, behaving mice. Importantly 
for future human use, we transfected neurons in adult mice with a fl uorescent calcium sensitive protein (GCaMP) 
using an adeno-associated virus. These advances open avenues for using other calcium detectors, such as the 
bioluminescent molecule aequorin that do not require specialized laser excitation equipment.
I enjoyed the invaluable guidance of Professor Nishimura during my time at the Leadership Program. I also enjoyed 
working closely with Nicholas Horton from Professor Chris Xu’s lab, and Raymond Xu. Drs. Parker, McGregor, and 
Fraser have provided excellent modules and plenty of insightful discussion. Credit is due to Zoetis Inc. for facilitating 
my time here.  
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Krystana Föh, Freie Universität Berlin, Immunology
Chemokine expression in neonatal mice infected with murine cytomegalovirus
During my time at Cornell I gained a lot of research experience, but I also enjoyed 
meeting the wonderful and interesting people who participated in the program from 
throughout the world. Thanks to the program’s infl uence I can now say that a career 
in research is what I intend to pursue. I spent this summer in Dr. Brian Rudd’s Lab 
in the Department of Immunology and Microbiology participating in a research 
project focused on the role of CD8 T-cells in controlling cytomegalovirus infection.  
Human cytomegalovirus (HCMV) infection is a major public health concern. HCMV 
can cause brain damage with severe neurological sequelae in congenitally infected 
children and is the leading cause of birth defects and childhood disorders in 
children in the United States.
The Rudd lab had previously shown that the chemokine CCL25, which is involved in 
homing of T-cells to the gut, also plays a role in homing of CD8 T-cells to the brain 
of mice infected with murine cytomegalovirus (MCMV). My project this summer 
focused on the visual verifi cation of the chemokine CCL25 and its receptor CCR9 
in the brains of MCVM infected neonatal mice. After developing the protocol, I used 
immunofl uorescence confocal microscopy to image brain tissue of mice at different stages of infection. I found that 
cells in a specifi c region of the brain express CCL25 and its receptor CCR9 at a particular stage of MCMV infection. 
I would like to thank Dr. Brian Rudd and Charles Wisler for guiding me through my fi rst research experience as well 
as our facilitators, program directors, program coordinators and my fellow students for making this summer so 
inspiring and valuable. I would also like to thank the DAAD for fi nancial support.
Lucy Hardwick, University of Liverpool, Virology
The localization of cellular translation proteins in cells infected with mammalian 
orthoreovirus. 
One of the things that surprised me when I started vet school was just how much 
is ‘not really known’ in veterinary medicine and this was what originally sparked 
my interest in research.  Now as I am about to enter my 3rd year I have been lucky 
enough to partake in the Cornell Leadership Program and have had the opportunity 
to carry out some research. 
My research project this summer compared the localization of cellular translation 
proteins in cells infected with two strains of mammalian orthoreoviruses.  Previously 
the Parker lab had shown that infection with one reovirus strain, Type 3 Dearing 
(T3D), redirects translation to the cytosolic sites of viral replication known as viral 
factories. Although, cellular translation factors are redirected to the T3D viral 
factories, infection with T3D has minimal effect on cellular translation.  In contrast, 
infection with the Type 3 Abney (T3A) strain of reovirus strongly inhibits cellular 
translation. In order to assess the role of translational compartmentalization in shut 
down, I compared the distribution of cellular proteins associated translation in the 
viral factories of cells infected with T3D and T3A. I found that the distributions of these proteins were similar in cells 
infected with T3D and T3A.
I would like to thank the entire Parker Lab for all their help in introducing me to the world of research, but in 
particular Dr. Emily Desmet for her never faltering patience and guidance when teaching me new techniques. In 
addition I would like to thank Drs. Parker, McGregor and Fraser for such a fantastic program and the Wellcome Trust 
for their funding which enabled me to participate in this wonderful opportunity.
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Lauren Healy, Cornell University, Chemical Engineering 
TatA and Amphipathic Proteins: A new design for studying membrane bound 
proteins
Less than 1% of known protein structures are membrane proteins. The DeLisa lab 
in Olin Hall is attempting to fi nd a new way to study these elusive proteins. The goal 
is to create a “nanobelt” of an amphipathic protein for the membrane protein to sit 
inside. This enables the protein to be placed in an aqueous medium and studied 
using x-ray crystallography. I worked on applying this technique to the A subunit of 
the twin arginine translocation pathway protein from E. coli. The TatA protein was 
expressed either one, two, or three times in a row preceded by a soluble signal 
sequence, and followed by either PSAM or ApoA1 - two nanobelt proteins. 
We created constitutively active, membrane bound versions of TatA to show that 
our TatA construct does form pores. It is postulated that the amphipathic domain of 
TatA fl ips up to create these pores. To test this we created a TatA-Fos-B-lactamase 
construct, where the Fos-B-lactamase is located in the cytoplasm, and the Jun-B-
lactamase construct is in the periplasm. When the B-lactamase subunits combine, 
it creates ampicillin resistance. The Tat system is used by a multitude of pathogens, 
and understanding how it fully functions is crucial towards attempting to use it as a target for new therapeutics. 
I would like to thank Dr. Matthew DeLisa and Dr. Dario Mizrachi for all of their guidance and time, and Drs. Fraser, 
Parker, and McGregor for all the time they spent to put together this wonderful program. This project was supported 
by funding from Zoetis Inc.
Aimée Heinz, Freie University of Berlin, Neurobiology
Protocadherin19 and its function in Epilepsy with Mental Retardation limited to 
Females
The Leadership Program has given me the opportunity to experience research and 
learn about the variety of career pathways available for veterinarians. 
Epilepsy with Mental Retardation limited to Females (EFMR) is an X-linked dominant 
disorder characterized by early onset febrile seizures and varying degrees of 
cognitive impairment. Mutations in the Protocadherin19 (Pcdh19) gene are the sole 
cause of EFMR, yet how Pcdh19 causes such a dramatic phenotype is unknown. 
Pcdh19 is a member of the cadherin superfamily, a group of axon guidance cue 
molecules characterized by calcium-dependent cell-cell adhesion. Due to its weak 
adhesive properties, Pcdh19 was primarily thought to play a role in intracellular 
signaling. This summer, I showed for the first time, that Pcdh19 is an important 
player in axon guidance and neurite outgrowth. By co-immunoprecipitation 
experiments, I found that Neural-Cadherin (NCad), a classical cadherin that is 
known to play an important role in axon guidance, interacts with Pcdh19. In 
addition, I demonstrated that this interaction can produce distinct phenotypes on 
neurite outgrowth. These results suggest that nonfunctional mutants of Pcdh19 might disrupt critical interactions 
with Ncdh and other molecules and therefore represent an important factor in axon guidance and neurologic 
diseases. 
I would like to thank Prof. Lin for his excellent mentorship and guidance, Sierra Palumbos and Ayaka Sugiura for 
their patient help, enthusiastic support and amazing friendship. I would also like to thank Drs. Parker, Frazer and 
McGregor for enabling my participation in this extraordinary program. Funding support was generously supplied the 
Bostwick Foundation. 
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Silvia Janská, The Royal Veterinary College, London, Virology
The Role of Mesenchymal Stem Cells (MSC) during Equine Herpes Virus Type 1 
(EHV-1) Infection
Although initially interested in becoming an equine specialist, my career aspirations 
are shifting towards combining essential clinical knowledge with scientifi c 
training to allow me to contribute to progress in human and veterinary medicine 
in my chosen fi eld of research. As a fi nal year veterinary medicine student, the 
Leadership Program presented itself as an ideal opportunity to further develop my 
basic science research skills and to explore the different professional opportunities 
available to veterinarians. 
During the program, I worked in Dr. Gerlinde Van der Walle’s Lab at the Baker 
Institute, where I investigated the role of Mesenchymal Stem Cells during Equine 
Herpesvirus type 1 (EHV-1) infection. Given the increased prevalence of equine 
herpes myeloencephalopathy caused by EHV-1, the lack of an effective vaccine, 
and a debate as to which cell type carries EHV-1 during viremia, my aims were (i) to 
evaluate the replication properties of neurological and non-neurological biovariants 
of EHV-1 in equine MSCs in vitro, (ii) to isolate and grow MSC from blood samples of 
horses before and after infection with EHV-1 and (iii) to investigate the presence of EHV-1 in MSC in vivo. While I was 
successful in isolating equine MSCs, the rest of the data are still pending.
A special thanks goes to my mentor Dr. Gerlinde Van de Walle as well as the other laboratory members for 
supervision, guidance and the wonderful time I had this summer. I would also like to thank the program facilitators 
and my fellow Leadership students for an unforgettable experience. I am also grateful for the funding support from 
the Wellcome Trust that allowed me to participate in this program. 
Nandita Kataria, University of Sydney, Cancer Biology 
Investigating the acute responses of testicular germ cell tumors to cisplatin
Whilst I somewhat naively decided to ‘become a vet’ at a young age, I was drawn 
to the discipline of cancer biology within the very fi rst few weeks of my veterinary 
degree. The Leadership Program has helped me realize that I must ultimately marry 
these clinical and bench-top aspirations, in order to most successfully tread the fi ne 
line that is translational oncology.
Human testicular germ cell tumors (TGCTs) are highly responsive to DNA damaging 
chemotherapies such as cisplatin, and a better understanding of this phenotype 
could yield more effi cacious treatments for chemoresistant cancers. Previous 
studies by the Weiss lab showed that the suspected cancer stem cells (CSCs) 
of their novel TGCT model appeared diminished after long-term treatment with 
cisplatin. Based on this observation, we hypothesized that these CSCs are 
extremely sensitive to cisplatin, and that cisplatin treatment induces DNA damage 
responses (DDRs) which lead to apoptosis or senescence. We treated TGCT 
bearing mice with cisplatin, culled them acutely post treatment and then used 
immunohistochemistry to elucidate which DDR pathways had been activated. We 
found that many of the CSCs undergo a wave of apoptosis within 24 hours of treatment, whilst the remaining CSCs 
repair the cisplatin-induced damage and resume proliferation.
I would like to thank the members of the Weiss lab, especially Tim Pierpont, for being incredibly supportive and 
helpful throughout the project. I’d also like to thank the coordinators of the Leadership Program, Drs Fraser, 
McGregor and Parker, for providing us with such an eye-opening, educational and all-round exhilarating summer at 
Cornell University. Last I would like to thank Zoetis Inc. and the Bostwick Foundation for providing the funding for my 
participation in the program.
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Wilfred Leung, University of Queensland, Structural Biology
Investigating biofi lm formation in bacteria
The potential to head into a research based Veterinary sciences career has always 
been on my mind since starting vet school, however it was only after I started the 
Cornell Veterinary Leadership Program did I realize the limitless opportunities out 
there for someone with a veterinary degree. The program has also helped me to 
narrow my focus to the careers I am interested in and to evaluate the best way to 
reach my career goals.
My research project involved looking at biofi lm formation in bacteria using a 
structural protein biochemistry approach. Biofi lm is a protective physical matrix 
formed by bacteria to prevent their removal making it a huge problem especially 
in persistent nosocomial infections. Research in our laboratory currently focuses 
on a pathway used by bacteria to detect environmental levels of phosphate and 
through a signaling network, either promote or inhibit the formation of biofi lms. 
My project involved investigating the LapG and LapA interaction role in biofi lm 
dispersion in Pseudomonas fl uorescens. Using a novel crosslinking method, I was 
able to show the residues on LapG which are important for the interaction with 
LapA. This crosslinking method can be used to fi nd interacting partners in other, more pathogenic bacteria such a 
Pseduomonas aeruginosa and Legionella pneumophila. 
I would like to thank my mentor Dr. Holger Sonderman and Dr. Rick Cooley for providing me with great guidance 
and the program coordinators, Drs. Parker, McGregor and Frazer. I would like to thank Zoetis Inc. and the Bostwick 
Foundation for funding my Leadership Program and the University of Queensland for award of the UQ Advantage 
Grant. 
Jenny Munhofen, University of Georgia, Molecular Biology
Analysis of Mitochondrial Targeting Sequences using GFP Vector in Tetrahymena 
thermophila
As a rising second year veterinary student with a Master’s degree in vertebrate 
fi eld research, I chose the Cornell program for the chance to gain exposure to 
lab research. The Leadership Program granted more than just lab work, but truly 
afforded me a unique opportunity through seminars and modules to the varied 
career paths in veterinary research. I hope to earn a position in the US Army 
Veterinary Corp and pursue postgraduate research and a residency in pathology. 
The Clark lab focuses on the biology of host-pathogen interactions, and, more 
broadly, the control of infectious disease using Tetrahymena thermophila, a 
protozoan, as the model organism. The Clark lab recently discovered when these 
single cell eukaryotes undergo stress, they will jettison whole, intact mitochondria 
without cell lysis, but the active release of entire mitochondria has never been 
documented in live cells. My summer project has been to insert four different 
mitochondrial-targeting genes into a GFP vector, shoot the vector into Tetrahymena 
in order to determine which leader sequence was most effective using fl uorescent 
and confocal microscopy in live cells. Our results showed that all four leader sequences are able to target the 
mitochondria and goal is to capture this phenomenon in real time. 
I would like to thank Dr. Ted Clark and Dr. Donna Cassidy-Hanley for their mentorship and the blessed opportunity to 
join the most outstanding lab for my summer experience! The camaraderie, positive attitudes, and fun atmosphere, 
set this lab apart from all others and I am so grateful to have met such amazing people!  Last I would like to thank 
Zoetis Inc. for funding my summer program.
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Tessa Procter, University of Bristol, Immunology
Characterising an IL-22 Binding monoclonal antibody in a biological context
I applied to the Cornell Veterinary Leadership Program hoping to gain insight into 
careers I could undertake with my veterinary degree as well as gain more research 
experience. The Leadership Program has lived up to expectations and provided 
me with a myriad of options. The research experience I have gained has further 
cemented my plans to pursue a research-orientated career.
This summer I spent time in Dr. Doug Antczak’s laboratory, where research focuses 
on equine reproductive immunology and genetics. Initially, my project was aimed 
at providing evidence for the production of an IL-22 binding protein (IL-22BP) in 
equine peripheral blood mononuclear cells (PBMCs). Very little is known about IL-
22BP making it extremely exciting to investigate. The lab has produced monoclonal 
antibodies to IL-22BP that I used to identify the presence of this protein in equine 
PBMCs using fl ow cytometry. Upon starting the project we found that the antibodies 
made required further characterization. Therefore, my project was extended to 
include this aspect of research. I am grateful to have been given this opportunity to 
learn new skills, which I will be able use throughout my career.
I would like to thank Dr. Antczak, Becky Harman, Don Miller and Peggy Brosnahan for their guidance and support 
throughout the summer. Many thanks also go to Drs. Parker, Fraser and McGregor for a brilliant program, as well 
as my fellow participants for making this a memorable summer. I would also like to thank the Wellcome Trust for 
fi nancially supporting me during the program.
Marieke Ravenek, Utrecht University, Gastroenterology
Identifi cation of Genes in Adherent and Invasive Escherichia Coli (AIEC) Required 
for Epithelial Cell Invasion by Signature-Tagged Mutagenesis
When I started veterinary school, I was planning to go into private practice. Over 
the years my interest has been raised to pursue a career as a specialist and 
researcher. This program has provided me with more research training and a better 
understanding of career opportunities outside of private practice.
Adherent and invasive E. coli (AIEC) are a novel pathotype of E. coli implicated in 
the development of ileal Crohn’s disease (CD). AIEC can invade epithelial cells, 
persist and replicate in macrophages and exploit genetic defects associated 
with CD. The bacterial factors encoding virulence are unclear. Signature-tagged 
mutagenesis has identifi ed mutants in AIEC NC101 that are less able to invade 
Caco-2 intestinal epithelial cells. The genes affected by these insertions have 
been identifi ed and my work was focused on creating plasmids containing 
candidate genes that were used to complement these less invasive mutants. 
After complementation, I worked on comparing the motility and the ability of wild 
type, transposon-disrupted, and complemented strains to invade Caco-2 intestinal 
epithelial cells.
I want to thank Dr. Kenneth Simpson and Dr. Belgin Dogan enormously for their supervision and support this 
summer and I want to thank all the other members of the Simpson lab for all the good times. Special thanks to 




Hendrik Sake, Tierärztliche Hochschule Hannover, Virology
The Role of Matrix-Metalloproteinases in Feline Infectious Peritonitis virus (FIPV) 
infection.
The Cornell Leadership Program was an excellent way to broaden my horizon in 
many ways. Getting in contact with so many different people, cultures and career 
opportunities was something I really enjoyed. Before I came to Cornell I had not 
been exposed to research at all, but this program gave me the unique opportunity 
to explore different veterinary career paths that differ from the traditional clinical 
pathway.
Feline infectious peritonitis (FIP) is a deadly infectious disease of cats. It is caused 
by a feline coronavirus called FIPV that derives from a benign feline enteric 
coronavirus (FECV) by mutation. The clinical presentation of the disease is divided 
into a wet and a dry form. In the wet form of the disease fl uid accumulates in body 
cavities as a consequence of increased vascular permeability caused by virus 
infection.
My research project this summer focused on the role of matrix metalloproteinases 
(MMPs) in the disease progression of FIP. We hypothesized that MMPs play an important role as an activator for 
virus-entry into monocytes and whose activation causes a proteolytic cascade that ultimately leads to increased 
vascular permeability. Using PCR and qPCR I was able to fi nd evidence that the production of MMP2 and MMP9 in 
monocytes is up regulated following FIPV infection.
I would like to thank Dr. Gary Whittaker, my fellow lab members, and in particular Dr. Beth Licitra for their help and 
support this summer. Furthermore I want to thank the Cornell Feline Health Center, the Bostwick Foundation, the 
DAAD and Boehringer Ingelheim for their fi nancial support.
Neharika Saxena, RAJUVAS, Bikaner, India, Molecular Biology
Cloning of Brucella canis gene for production of an immunodominant antigen for 
diagnostic use
When I began the Leadership Program I had very little experience in research. 
During this summer I learned to be organized and I learned the basics of 
molecular biology and molecular cloning.
A previous Leadership Program student had begun this project last year and she 
had identifi ed 12 genes that coded for immunodominant proteins in B. canis. My 
project was to clone several of these genes into a protein expression vector and 
then to purify the proteins for use as an antigen to prepare antibodies against B. 
canis. To accomplish this, my plan was to use an expression vector system that 
produces an inducible histidine-tagged construct so that the resulting product 
may be purifi ed by affi nity chromatography. I used PCR to amplify the genes of 
interest using B. canis genomic DNA as the template and primers derived from 
the sequence of the genes of interest. These genes were to be cloned into pQE60 
(Qiagen Inc.) to create a fusion protein carrying six additional histidine moieties at 
the carboxyl terminus of each fusion protein.
Although I was able to successfully PCR amplify several of the genes of interest from B. canis genomic DNA. I 
was unable to clone these PCR products into the vector because of problems with the ligation reactions. After 
troubleshooting, I found that one of the restriction enzymes I used did not work. Although I was able to use 
appropriate controls to identify the problem due to time constraints, I was unable to complete the project. However, 
the lessons learned during this study will form the basis of more fruitful work in the future. My special thanks go to 
Dr. Craig Altier for the opportunity to work in his lab and for having enormous patience with me, Prof. David Fraser for 
encouraging me, Iva, Carrie and Steffi e for guiding me and Emily, Jenny, Hannah and Helena for being so sweet to 
me. I also thank Zoetis Inc. and the Bostwick Foundation for providing a scholarship that allowed me to attend.
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Svenja Wiechert, Tierärztliche Hochschule Hannover, Pathology
Platelets as a potential transportation for EHV-1
The Cornell Leadership Program gave me a one-time opportunity to gain an insight 
into research before graduation, and enhanced my scientifi c education. It also 
provided an inspiring atmosphere of teamwork, ambition and science that I will 
never forget.
Equine Herpesvirus-1 (EHV-1) can cause myeloencephalopathy in horses by 
inducing vasculitis and thrombosis in the meninges. This then causes ischemic 
necrosis of the spinal cord. A key question is how does the virus access the 
meninges after aerosol infection. Although leucocytes have been implicated as 
‘transporters’ for the virus, initial experiments in the Stokol laboratory indicated 
that EHV-1 can infect and activate platelets, which are key players in thrombosis.
We hypothesised that the virus uses platelets as an additional mode of 
transportation to the meninges. Equine carotid artery endothelial cells (CAECs) 
were grown in microfl uidic channels to simulate a capillary. We then infected 
platelets with EHV-1 and watched for interactions with endothelial cells under 
physiological conditions of blood fl ow rate. We found evidence that activated platelets rolled on and bound to the 
endothelial cells more frequently compared to the control. Investigating the possible routes of transmission of EHV-1 
within the horse’s body will lead to a better understanding of the pathogenesis of this important infectious disease 
of horses.
I would like to thank Professor Stokol for the opportunity to experience research in her laboratory and for her great 
mentorship. I would also like to thank all the lab members especially Dr. Yeo for their support and encouragement.
I am grateful to be funded by Boehringer Ingelheim, the DAAD and the Bostwick Foundation. Last but not least I give 
thanks to Drs Parker, McGregor and Fraser for organizing this great program.
Stefanie Witte, Tierärztliche Hochschule Hannover, Molecular Biology
Microvesicles: A new form of Stem Cell Communication
Since entering veterinary school in 2010, I have been interested in research. This 
summer the Cornell Leadership Program gave me the opportunity to work in a basic 
research laboratory, as well as to learn about different career paths. 
My research project for the summer was focused on an unusual form of cell-to-cell 
communication that involves microvesicles (MVs). These large membrane-enclosed 
packets of proteins, RNA transcripts and micro-RNAs are shed from the surfaces 
of cells and can be transferred to other cells where they alter the behavior of the 
recipient cell. For example, the Cerione lab has shown that aggressive forms of 
human cancer cells produce MVs that can transiently transform a normal (non-
transformed) recipient cell. However, these fi ndings raise the important question 
whether normal cell types also generate MVs and what their function is. 
This summer I found that totipotent embryonic stem (ES) cells also generate MVs. 
Moreover, cardiomyocytes and neurons derived from ES cells continue to produce 
MVs. I then went on to show that MVs from ES cells and cardiomyocytes were able 
to promote the survival of the recipient fi broblasts. Thus, these fi ndings suggest that MVs represent a common form 
of cell-to-cell communication and that they may have important consequences in development and regenerative 
medicine. I would like to thank the members of the Cerione lab for their support and guidance, especially Laura 
Desrochers and Marc Antonyak. I would also like to thank Drs. Parker, McGregor, and Fraser who gave me the 
opportunity to have this valuable experience at Cornell and to get to know several amazing people. Last I would like 
to thank Boehringer Ingelheim, the DAAD and the Bostwick Foundation for their support.
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Bosco Yeung , Royal Veterinary College, Biomedical Engineering
In vivo Two-Photon Microscopy Imaging of Atherosclerotic Plaque in Rodent Carotid 
Artery
Having worked as a clinical pharmacist for two years before entering veterinary 
school, my career interest in translational science combining a research and 
clinical component has always been my career goal. The Leadership Program 
provided an excellent grounding in decision-making and critical thinking, and also 
equipped me with hands-on research skills that I will need to pursue my long term 
academic research plan.
My research project under the mentorship of Professor Nishimura focused on in 
vivo two-photon microscopy imaging of the rodent carotid artery. Our aim is to 
understand the in vivo dynamics of atherosclerosis in a rodent model, focusing on 
the formation and rupture of atherosclerotic plaques and the role of infl ammation 
in the disease. In order to develop this novel in vivo imaging technique, I used a 
rodent model of atherosclerosis. I then surgically placed a GRIN (gradient-index) 
lens into the common carotid artery and used two-photon excited fl uorescence 
microscopy to look at the internal structure of the carotid artery. I was able to see 
autofl uorescence from the internal aspect of the carotid artery. Future application of this technology would focus 
on monitoring the cellular pathophysiology of atherosclerosis by looking at plaque formation, and the leukocyte and 
monocyte response in the native plaque environment. 
I would like to extend my heartfelt thanks to 
Professor Nishimura and the Schaffer-Nishimura 
lab for their tremendous support and motivation 
throughout this summer.  I want to express my 
gratitude to Drs. McGregor, Fraser and Parker for 
their wholehearted support throughout the program 
and to the Wellcome Trust for their fi nancial support. 
Additionally, I would like to wish all my peers the 
best in their future pursuits.
Research is to se
e what 
everybody else h
as seen, and 
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Dr. Jenny Sones, Facilitator
Graduate Research Fellow 
Biomedical Sciences
Cornell University
Dr. Susan Tornquist 
Facilitator
Associate Dean of Student 
and Academic Affairs and 
Professor, Clinical Pathology
Oregon State University
Dr. Alfonso Torres, Facilitator
Associate Dean for Public 
Policy, Cornell University









Dr. Robin Yates, Facilitator
Associate Professor 
Comparative Biology and 
Experimental Medicine
University of Calgary
The task of the 
leader is to get 
his people from w






Participants in the Leadership Program were housed in 
the Zeta Psi fraternity house on the Cornell campus. They 
had exclusive use of the building for the ten-week period 
that the program was in session. Several events were 
scheduled there, typically in the evening in conjunction 
with a catered meal. The living arrangements enabled 
the scholars to socialize and relax in a convenient and 
pleasant campus environment.  
Housing
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Time Out
Apart from their intensive schedule, program scholars 
found time for many personal pleasures. They capitalized 
on local Ithaca amenities and visited natural sites of 
beauty and cultural centers within striking distance of 
Ithaca.
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The Leadership Program scholars hosted a dinner for 
their mentors, module facilitators, counselors, and other 
guests at Willard Straight Hall on the Cornell University 
campus.
Program Dinner
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Contact with Leadership Program graduates is maintained in order to strengthen the professional network forged at 
Cornell and to uphold the program’s tradition of excellence for the benefi t of future scholars. Alumni are encouraged 
to make informed decisions about the advanced training needed to realize their professional goals. The accompany-
ing table lists degrees awarded to program graduates and degrees they are expected to receive after completing the 
academic programs in which they are presently registered. Not included in the table are individuals who have not yet 
graduated with the DVM or its equivalent and program alumni who were awarded advanced degrees in science prior 
to their enrollment or to their enrollment in a veterinary degree program.
Academic Qualifi cations of DVM alumni of the 
Leadership Program (1990-2012)
  DEGREE    NO. % NORTH AMERICAN NO. % OTHER COUNTRIES  NO. % TOTAL ALUMNI
     ALUMNI     ALUMNI
  PhD                                                
  Dr. Med. Vet.                                                               
  MPH                                                            
  MS                                                       
  NA = Not applicable
 
        
The following table indicates that a substantial number of program alumni obtained residency training in the course 
of their graduate studies. One hundred and one of these individuals were graduates of veterinary schools in North 
America while fi fty-two were alumni of schools located elsewhere in the world. It is tempting to speculate that the dif-
ference between the two groups refl ects greater opportunities for residency training in North America although other, 
less obvious reasons may contribute to the observed difference.
Residency Training of DVM Alumni of the Leadership Program (1990-2012)
         NO. % NORTH AMERICAN ALUMNI        NO.          % OTHER ALUMNI       % TOTAL 
                 ALUMNI 
                     101             38.3%          52                 20.9%    29.8%
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Where Are They Now?
Listed below are the positions currently occupied by 
program alumni whom have completed their veterinary 
education and are pursuing careers in science or public 
health.
1990
John Angelos, Associate Professor, Comparative Pathol-
ogy, University of California at Davis, CA
William Carr, Instructor, Ragon Institute, MGH, Harvard 
University, Cambridge, MA 
Laura Gumprecht, Associate Director, Safety Assess-
ment, Merck Research Laboratory, West Point, PA
Elizabeth Lyon-Hannah, Research Faculty, Boise State 
University, Boise, ID
Richard Haworth, Senior Pathologist, GlaxoSmithKline, 
Middlesex, UK
Melissa Mazan, Associate Professor and Director, Sports 
Medicine, Tufts University, North Grafton, MA
Rebecca Papendick, Diagnostic Pathologist/Senior Sci-
entist, Zoological Society of San Diego, San Diego, CA
Susan Schaefer, Clinical Associate Professor, Surgery, 
University of Wisconsin, Madison, WI 
A. W. (Dan) Tucker, Senior Lecturer, Veterinary Public 
Health, University of Cambridge, UK
Thomas Vahlenkamp, Head, Institute of Virology, School 
of Veterinary Medicine, Leipzig, Germany
1991
Prema Arasu, CEO/Vice Provost, Kansas State University, 
Olathe, KS
David Bainbridge, Clinical Veterinary Anatomist, Univer-
sity of Cambridge, UK
Linda Berent, Clinical Associate Professor, University of 
Missouri, Columbia, MO
Ian Davis, Associate Professor, Veterinary Biosciences, 
The Ohio State University, Columbus, OH
Dianne Hellwig, Associate Professor, Agriculture and 
Natural Resources, Berea College, KY
Judy Hickman-Davis, Director, Laboratory Animal Training 
Program/Associate Professor, Department of Veterinary 
Preventive Medicine, The Ohio State University, Colum-
bus, OH
Alison Moore, Equine Medical Consultant, IDEXX, Cam-
bridge, Ontario, CA
Alan Radford, Senior Lecturer, Small Animal Studies, 
University of Liverpool, UK
1992
Tomasz Betkowski, Business Manager, Quintiles, 
Warszawa, Poland
Stephen Davies, Associate Professor, Parasitology, Uni-
formed Services University, Bethesda, MD
Mathew Gerard, Associate Professor, Anatomy/Surgery, 
North Carolina State University, Raleigh, NC
Jacqueline Phillips, Professor, Molecular Neuroscience, 
Macquarie University, Sydney, AU
Cristina Rodriguez-Sanchez, Senior Research Associate, 
Universidad Nacional Autónoma de México, Mexico
Louise Southwood, Associate Professor, Large Animal 
Emergency and Critical Care, University of Pennsylvania, 
New Bolton Center, Philadelphia, PA
Reinhard Straubinger, Professor and Section Head, Bac-
teriology and Mycology, Ludwig Maximillian University, 
Munich, Germany
1993
Virginia Fajt, Associate Professor, Pharmacology, Texas 
A&M University, College Station, TX 
Christopher Laing, Director, Science and Technology Uni-
versity City Science Center, Philadelphia, PA
Emma Massey O’Neill, Lecturer, Small Animal Medicine, 
University College, Dublin, Ireland
Ashley Reynolds, Supervisory Public Health Veterinarian, 
Food Inspection and Safety Service, USDA, Philadelphia, PA
Susannah Ryan, Director Scientifi c Services, ApotheCom 
ScopeMedical Europe, London, UK
Veiko Saluste, Chief Executive Offi cer, Interchemie 
Worken, Adelaar AS, Estonia
Melinda Stewart-Gabor, Pathologist, Elizabeth MacArthur 
Research Laboratory, Sydney, AU
Lynn Wachtman, Clinical Veterinarian and Instructor, New 
England Primate Center, Harvard Medical School, South-
borough, MA
1994
Melissa Beall, Research Scientist, Medical Affairs, IDEXX 
Inc., Portland, ME
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Larissa Bowman, Director, Mountain Veterinary Pathol-
ogy, Ashville, NC
Leslie Gabor, Manager, Pre-Clinical Safety, Novartis Ani-
mal Health, Sydney, AU
Maria Lara-Tejero, Senior Research Associate, Depart-
ment of Microbiology, Yale University, New Haven, CT
Christopher Mariani, Associate Professor, Neurology, 
North Carolina State University, Raleigh, NC
Sonia Mumford, Veterinary Medical Offi cer, Olympia Fish 
Health Center, U.S. Fish & Wildlife Service, Olympia, WA
Jeffrey Phillips, Assistant Professor, Oncology and Medi-
cal Genetics, University of Tennessee, Knoxville, TN
Julie Pomerantz, Associate Research Scientist, Wildlife 
Trust, Palisades, NY
Stacy Pritt, Director and General Manager, Biological Test 
Center, B. Braun Medical, Irvine, CA
Mary Thompson, Lecturer Small Animal Medicine, Uni-
versity of Queensland, AU
Oliver Turner, Senior Pathologist, Novartis Institute for 
Biomedical Research, East Hanover, NJ
1995
Gertraut Altreuther, Project Manager, Parasitology, Bayer 
Animal Health, Leverkusen, Germany
Philippa Beard, Lecturer, Pathology and Virology, Univer-
sity of Edinburgh, UK
Kate Creevy, Assistant Professor, Small Animal Medicine, 
University of Georgia, Athens, GA
Rachael Gray, Senior Lecturer, Veterinary Anatomy, Uni-
versity of Sydney, AU
Wendy Harrison, Research Scientist, GlaxoSmithKline, 
Medicines Research Center, Stevenage, UK
Andrew Moorhead, Assistant Research Scientist, Infec-
tious Diseases, University of Georgia, Athens, GA
Tony Mutsaers, Professor, Clinical Studies, Ontario Veteri-
nary College, Guelph, Ontario, CA
1996
Mark Doherty, Technical Service Manager, Ancare, Kir-
rawee, NSW, AU
Michelle Dries-Kellaway, Senior Regional Coordinator, De-
partment Premier and Cabinet, NSW, AU
Patricia Gearhart, Adjunct Assistant Professor, Ophthal-
mology, Michigan State University, East Lansing, MI
Tamara Gull, Assistant Professor, Pathobiology, Oklaho-
ma State, Stillwater, OK
Antonia Jameson-Jordan, Lecturer, Department of Bio-
medical Sciences, Cornell University, Ithaca, NY
Ralph Senften-Rupp, Head, Information Technology, 
Provet AG, Berne, Switzerland
John Stein, Resident, Diagnostic Imaging and Radiology, 
University of Wisconsin, Madison, WI
Allison Stewart, Associate Professor, Equine Internal 
Medicine, Auburn U., AL
Edwin van Duijnhoven, Research Scientist, NOTOX, the 
Netherlands
Constantin Von der Heyden, Director, Pegasys Strategy 
and Development RSA, South Africa
1997 
Peter Bracken, Technical Services Veterinarian, Boeh-
ringer Ingelheim, AU
Jonathan Happold, Senior Veterinary Offi cer, Epidemiol-
ogy, AGDAFF, AU
Tanya LeRoith, Clinical Assistant Professor, Pathology, 
Virginia Tech, Blacksburg, VA
Lucy Neave, Lecturer, Creative Writing, Australian Na-
tional University, Canberra, AU
Patricia Pesavento, Associate Professor, Pathology, Uni-
versity of California, Davis, CA
Paul Plummer, Assistant Professor, Microbiology, Iowa 
State University, Ames, IA
Jonathan Werner, Principal Pathologist, Amgen, Inc., 
Thousand Oaks, CA
Esther Wissink-Antonis, Research Manager/Faculty, Virol-
ogy, University of Utrecht, the Netherlands
Rachel Walker, PhD candidate, Pathology, University of 
Sydney, AU
Rebbecca Wilcox, Animal Welfare Offi cer, RMIT Univer-
sity, Melbourne, AU
1998
Max Bastian, Senior Scientist, Paul Ehrlich Institute, 
Langen, Germany
Steven Fleisher, Biologist, Center for Biologics Evaluation 
and Research, FDA, Bethesda, MD     
Karsten Hüffer, Associate Professor, Microbiology, Insti-
tute of Arctic Biology, University of Alaska, Fairbanks, AK
Mary Klinck, PhD candidate, Pharmacology, University of 
Montreal, Montreal, CA
Karen Liljebjelke, Assistant Professor, Microbiology, Uni-
versity of Calgary, Alberta, CA
Larissa Minicucci, Director, D.V.M./M.P.H. Program, Uni-
versity of Minnesota, Minneapolis, MN 
Amanda de Mestre, Lecturer, Veterinary Basic Sciences, 
Royal Veterinary College, London, UK
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Erin Phipps-Crotty, Public Health Specialist, New Mexico 
Dept. of Health, Albuquerque, NM 
Anne-Marije Sparnaaij, Senior Policy Advisor, Ministry of 
Agriculture, the Netherlands
1999
Erica Behling-Kelly, Assistant Professor, Clinical Pathol-
ogy, Cornell University, Ithaca, NY
Nadine Bowden, Postdoctoral Fellow, Cardiology, NIH, 
Washington DC
Christine Broster, Veterinary Clinical Training Advisor, The 
Brooke, UK
Robert Dickens, Training Specialist, U.S. Department of 
Agriculture, Raleigh, NC
Joshua Fine, Program Manager, SAIC, Animal Disease 
Center, Plum Island, NY
Peter Florian, Director of Pharmacology R&D, Sanofi , 
Frankfurt, Germany
Carl Holmgren, Research Scientist, Université de la Médi-
terranée, Marseille, France
Emily Meseck, Senior Pathologist, Wyeth Research Labo-
ratories, Chazy, NY
Rachel Peters, Senior Scientist, Millennium Pharmaceuti-
cals, Boston, MA
Mary Nabity, Clinical Assistant Professor, Texas A&M 
University, College Station, TX
Kimberly Newkirk, Assistant Professor, Anatomical Pa-
thology, University of Tennessee, Knoxville, TN
Christopher Premanandan, Assistant Professor, Veterinary 
Biosciences, The Ohio State University, Columbus, OH
Rachael Tarlinton, Lecturer, Microbiology, University of 
Nottingham, UK
Holger Volk, Head, Queen Mother Hospital for Animals, 
Royal Veterinary College, London, UK
2000
Stephen Daley, Postdoctoral Fellow, Immunology, Austra-
lian National University, Canberra, AU 
Katharine Evans, PhD Candidate, Epidemiology, Univer-
sity of Nottingham, Nottingham, UK
Toby Floyd, Epidemiologist, Veterinary Laboratories 
Agency, Addleston, UK
Rachel Geisel-Allavena, Senior Lecturer, Pathology, Uni-
versity of Queensland, Brisbane, AU
Samuel Hamilton, Senior Veterinary Offi cer, Biosecurity 
Services, DAFF, Canberra, AU
Birgit Hingerl-Viertlboeck, Postdoctoral Fellow, Immunol-
ogy, University of Munich, Germany
Natali Krekeler, Lecturer, Veterinary Reproduction, Uni-
versity of Melbourne, Melbourne, AU
Jamie Lovaglio, Clinical Veterinarian, Pacifi c Northwest 
National Laboratory, Richland, WA
Richard Luce, Epidemiologist, US Centers for Disease 
Control and Prevention, Atlanta, GA
Fiona Norris-Sansom, Postdoctoral Fellow, Microbiology, 
University of Melbourne, AU
Knut Stieger, Research Leader, Faculty of Medicine, 
Ophthalmology, Justus – Lieberg University, Giessen, 
Germany
Joost Uilenreef, ECVAA Residency Supervisor, University 
of Utrecht, the Netherlands
Kevin Woolard, Assistant Professor, Pathology, University 
of California, Davis, CA
2001
Julie Chevrette, Head, Animal Environment, Montreal 
Heart Institute, Montreal, PQ
Karin Hölzer, ORISE Fellow, US Food and Drug Adminis-
tration, College Park, MD
Katherine Hughes, Lecturer, Veterinary Pathology, Univer-
sity of Cambridge, UK
Stephanie Janeczko, Medical Director, New York City 
Animal Care and Control, New York, NY
Charles Johnson, Postdoctoral Fellow, Comparative Pa-
thology, University of Minnesota, Minneapolis, MN
Robert Klopfl eisch, Assistant Professor, Pathology, Freie 
Universität, Berlin, Germany
David Loch, Postdoctoral Fellow, Queensland University 
of Technology, Brisbane, AU
Maeva May, AAAS Policy Fellow, National Cancer Insti-
tute, NIH, Bethesda, MD
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Timothy Myshrall, Assistant Director, Veterinary Services, 
Cleveland Clinic, Cleveland, OH
Judith Phillips, Postdoctoral Associate, Neurovirology, 
University of Pennsylvania, Philadelphia, PA
Kis Robertson, Preventative Medicine Fellow, Dept. 
Health and Mental Hygiene, Laurel, MD  
Simon Starkey, Education Veterinarian, Pet Smart Inc., 
Phoenix, AZ
Jason Stayt, Clinical Pathologist, Axiom Laboratories, 
Newton Abbot, UK 
Amy Warren-Yates, PhD Candidate, Neurobiology, Associ-
ate Professor, University of Calgary, Calgary, Alberta, CA
Rachel Windsor Ballantyne, Veterinary Technical Man-
ager, Merial Pharmaceutical, Stevenage, UK
Robin Yates, Associate Professor, Comparative Biology, 
University of Calgary, Calgary, Alberta, CA
Bevin Zimmerman, Assistant Director, Pathology, WIL 
Research Laboratories, Ashland, OH 
2002
Christine Bayley Trezise, Veterinary Pathologist, Gribbles 
Pathology, Melbourne, AU
Karin Darpel, Postdoctoral Scientist, Virology, Pirbright, UK
Karyn Havas, Veterinary Epidemiologist, U.S. Army,  Sur-
veillance Center, Silver Spring, MD
Patrick Kenny, Lecturer, Neurology and Neurosurgery, 
Royal Veterinary College, London, UK
Steven Laing, Resident, Pathology, University of Califor-
nia, Davis, CA
Susannah Lillis, Clinical Assistant, Professor, Radiology, 
University of Liverpool, UK
Anne Lo, Strategic Projects eCommerce, Worldpay, Lon-
don, UK
Michael Mienaltowski, Postdoctoral Fellow, Molecular 
Biology, University of South Florida, Tampa, FL
Andrew Miller, Head Diagnostic Services, New England 
Primate Research Center, Harvard Medical School, 
Southborough, MA
Simon Priestnall, Lecturer, Pathology, Royal Veterinary 
College, London, UK
Lisa Rose, Resident Radiology, Ohio State University, 
Columbus, OH
Kelly Still-Brooks, Major, Brigade Veterinary Surgeon, US 
Army, Fort Bragg, NC
Barbara Täennler Werhli, Marketing and Technical Man-
ager, Zoetis Inc., Zürich, Switzerland
2003 
Rosie Allister, PhD Candidate, Epidemiology, University of 
Edinburgh, UK
Mieke Baan, PhD Candidate, Endocrinology, University of 
Wisconsin, Madison, WI 
John Baker, Associate Consultant, Bain & Co., London, UK
Belinda Black, Resident, Large Animal Medicine, Ontario 
Veterinary College, Guelph, Ontario, CA
Patrick Carney, PhD Candidate, Epidemiology, Boston 
University, Boston, MA
David Gardiner, Pathologist, IDEXX Laboratories, Sacra-
mento, CA
Erika Gruber, Resident, Clinical Pathology, Cornell Univer-
sity, Ithaca, NY
Carol Haak, Resident Critical Care, University of Mis-
souri/Animal Emergency Center, Milwaukee, WI
Lindsay Hamilton, Research Veterinarian, Jurox Ltd, Ruth-
erford, AU
Michael Krahn, Assistant Professor, Cellular & Molecular 
Anatomy, University of Regensburg, Germany
Heather Martin, Laboratory Animal Veterinarian, Hoff-
man-LaRoche, Nutley, NJ 
Siobhan Mor, Lecturer, Food Safety, University of Sydney, 
Sydney, AU
Mayank Seth, Acting Head, Small Animal Medicine, Ani-
mal Health Trust, Cambridge, UK
Kate Patterson, Senior Science Writer, Garvin Institute, 
University of New South Wales, AU
Karla Stucker, Postdoctoral Fellow, J.Craig Venter Insti-
tute, Rockville, MD
Lyn Wancket, PhD candidate, Molecular Virology, The 
Ohio State University, Columbus, OH  
Christiane Wrann, Research Fellow, Medicine, Beth Israel 
Deaconess Medical Center, Harvard University, Cam-
bridge, MA
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2004     
Anton Asare, USDA Public Health Veterinarian, Univer-
sity of South Carolina, SC
Carolin Block, Clinical Trials Manager, Roche Pharma 
AG, Basel, Switzerland
Matthew Breed, PhD candidate, Immunology, Tulane 
University, Covington, LA
Andrew Broadbent, Postdoctoral Fellow, Virology, 
NIAID, NIH, Bethesda, MD
Karla Dreckmann, Research Scientist, Vaccine Devel-
opment, Boehringer Ingelheim, Germany
Annika Krengel, Veterinarian, Wilhelma Zoo, Stutt-
gart, Germany
Robert Ossiboff, Pathology Fellow, Bronx Zoo, New 
York, NY 
Sylvia Maliye, Senior Clinical Scholar, Surgery, Univer-
sity of Glasgow, UK
Allison Rogala, Resident, Laboratory Animal Medi-
cine, University of North Carolina, Chapel Hill, NC
Duncan Russell, Clinical Assistant Professor, Pathol-
ogy, The Ohio State University, Columbus, OH
Baukje Schouten-Schotanus, Postdoctoral Fellow, 
Cell Biology, University of Utrecht, the Netherlands
Katherine Scollan, Assistant Professor, Cardiology, 
Oregon State University, OR
Ivana Sekis Calice, Scientist, Baxter Innovations 
GmbH, Vienna, AT
Katy Townsend, Clinical Instructor, Surgery, The Ohio 
State University, Columbus, OH
Claire Underwood, Academic Clinician, University of 
Queensland, Brisbane, AU
2005  
Krystal Allen, Resident, Laboratory Animal Medicine, 
University of Pennsylvania, Philadelphia, PA
Melanie Ammersbach, PhD candidate, Ontario Veteri-
nary College, Guelph, Ontario, CA
Hannah Bender, Lecturer, Veterinary Pathology, Mur-
doch University, Perth, AU
Hille Fieten, PhD Candidate, Genetics, University of 
Utrecht, the Netherlands
Amanda Kreuder, PhD candidate, Iowa State Univer-
sity, Ames, IA
Rebecca Mitchell, Postdoctoral Fellow, Cornell Univer-
sity, Ithaca, NY
Marieke Opsteegh, Postdoctoral Fellow, Marie Curie 
Fellow, Moredun Research Institute, University of 
Edinburgh, UK
Emily Orchard-Mills, PhD Candidate, Psychology, University 
of Sydney, AU
Trisha Oura, Academic Tutor, North Carolina State Univer-
sity, Raleigh, NC
Johanna Rigas, Instructor, Clinical Pathology, Washington 
State University, Pullman, WA
Klara Saville, Service Offi cer, The Brooke, London, UK
Catherine Trickett, PhD Candidate, Animal Behavior, Bris-
tol University, UK
Nina Weishaupt, PhD candidate, Neuroscience, University 
of Alberta, Edmonton, Alberta, CA
2006
Onno Burfeind, Research Assistant, Clinic for Animal Re-
production, Freie Universität, Berlin, Germany
Bronwyn Clayton, Postdoctoral Fellow, Virology, CSIRO, 
Geelong, AU
Alexander Corbishley, PhD candidate, Immunology, Roslin 
Institute, University of Edinburgh, UK
Janny de Grauw, Postdoctoral Fellow, Faculty of Medicine, 
Utrecht University, the Netherlands
Louise Fitzgerald, Resident, Pathology, University of Penn-
sylvania, Philadelphia, PA
Anne Gordon-Schneider, PhD candidate, Cornell University, 
Ithaca, NY 
Annika Haagsman, Resident, Small Animal Surgery, Uni-
versity of Utrecht, the Netherlands
Eva-Marie Laabs, PhD candidate, Parasitology, Tierärztli-
che Hochschule, Hannover, Germany 
Jane Leadbeater, Medical Student, Griffi th University, 
Brisbane, AU
Gelja Maiwald, Head, Companion Animal Products, IDT 
Biologika, Dessau, Germany
Richard Meeson, Lecture, Surgery, Royal Veterinary Col-
lege, UK
Ashley Neary Hartley, PhD Candidate, University of Geor-
gia, Athens, GA
Joseph Neary, PhD Candidate, Epidemiology, Colorado 
State University, Fort Collins, CO
John Parker, PhD Candidate, Neurology, University of Cam-
bridge, UK
Tiffany Reed, PhD Candidate, Cancer Biology, NIH, Bethes-
da, MD
William Sander, AAAS Science and Technology Fellow, Offi ce 
of Human Health and Risk Assessment, Washington DC
Justine Shotton, MS Candidate, Wildlife Medicine, Royal 
Veterinary College, London, UK
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Laura Spoor, PhD candidate, Bacteriology, Roslin Insti-
tute, University of Edinburgh, UK.
2007 
Patrick Ayscue, Fellow, Science and Technology Policy, 
National Academy of Sciences, Washington D.C.
Sonja Bröer, PhD Candidate, Pharmacology, Tierärztliche 
Hochschule, Hannover, Germany
Stephen Burr, PhD Candidate, Immunology, Cambridge 
University, UK
Rosemary Brungs, Medical Student, University of Sydney, 
AU
Sarah Caddy, PhD Candidate, Virology, Imperial College, 
London, UK
Elva Cha, Principal Biometrician, Novartis, East Hanover, NJ
Boran Choi, MS candidate, Immunology, Seoul National 
University, Seoul, South Korea
Amy Fulton, Resident, Dentistry and Oral Surgery, Univer-
sity of California, Davis, CA
Ludwig Groebler, Veterinary Medical Educator, European 
Surgical Institute, Hamburg, Germany
Laura Grogan, PhD Candidate, Conservation Biology, 
James Cook University, AU
Kate Johnson, PhD Candidate, Clinical Science, Royal 
Veterinary College, London, UK
Kristin Lewis, Resident, Pathology, The Ohio State Univer-
sity, Columbus, OH
Ryan Traslavina, Postdoctoral Fellow, National Institute of 
Neurological Diseases and Stroke, NIH, Bethesda, MD
Maria Volkmann, PhD Candidate, Freie Universität, Ber-
lin, Germany
Annemarie Voorbij, PhD Candidate and Resident, Medi-
cine, University of Utrecht, the Netherlands
Shen Yang, Postdoctoral Fellow, Cell Biology, Eidgenös-
sische Technische Hochschule, Zürich, Switzerland
2008
Rachel Acciacca, Branch Chief, Veterinary Services, 
Camp Lejeune, Marine Base, NC
Hannes Bergmann, PhD Candidate, Australian National 
University, Canberra, AU
Jennifer Bernard, Resident, Pathology, University of Ten-
nessee, Knoxville, TN
Jennell Bigrigg, Resident, Comparative Pathology, Johns 
Hopkins University, Baltimore, MD
Anna Byron, M.S. Candidate, University of Sydney, Syd-
ney, AU
Lucie Chevallier, Resident, Pathology, Ecole Nationale, 
d’AlFort, Paris, France
Katharina Dinger, PhD Candidate, University Hospital, 
Cologne, Germany
Johanna Dups, PhD Candidate, Virology, CSIRO, Geelong, AU
Anna Heymer, Dr. Med. Vet. candidate, Nutrition, Tierärz-
tliche Hochschule, Hannover, Germany
Lisa Holz, PhD Candidate, Cardiology, University of Tübin-
gen, Germany
Sally Ann Iverson, ORISE Research Fellow, Plum Island 
Animal Disease Center, NY
Prabhpreet Kaur (nee Singh), Government Veterinarian, 
AVA, Singapore
Joshua Leach, MSc Candidate, Beatson Institute for Can-
cer Research, Glasgow, UK
Ming Lui, Intern, Emergency and Critical Care, Advanced 
Critical Care, Los Angeles, CA
Katherine McKelvey, Resident, Theriogenology, North 
Carolina State University, Raleigh, NC
Joanna Mleczko, PhD Candidate, Cornell University, 
Ithaca, NY
Dallas New, MSc Candidate, University of Saskatchewan, 
Saskatoon, SK, CA
Annelies Nijdam, Research Scientist, Hematology, Univer-
sity of Utrecht, the Netherlands
Jessica Privett, MPH Candidate, University of Sydney, 
Sydney, AU
Kimberley Schiller, Management Consultant, Accenture, 
London, UK
James Swann, Resident, Small Animal Medicine, Royal 
Veterinary College, London, UK
2009 
Floryne Buishand, PhD candidate and Resident, Small 
Animal Surgery, Cell Biology, University of Utrecht, the 
Netherlands
Nancy Erickson, PhD Candidate, Pathology, Freie Univer-
sität, Berlin, Germany
Laura Gey, PhD Candidate, Pharmacology, Tierärztliche 
Hochschule, Hannover, Germany 
Sonja Heinrich, Dr. Med. Vet Candidate, Institute for Zoo 
and Wildlife, Berlin, Germany
Alan Humphreys, Resident, Laboratory Animal Medicine, 
Baylor College of Medicine, Houston, TX
Shuhei Ito, PhD Candidate, Cellular Biochemistry, Univer-
sity of Tokyo, Japan
Beth Licitra, PhD Candidate, Cornell University, Ithaca, NY
Greta Schmoyer, Veterinary Medical Offi cer, USDA APHIS 
VS, Indianapolis, IN
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Meredith Sherrill, Resident, Small Animal Medicine, Uni-
versity of Missouri, Columbia, MO
Elizabeth Slack, PhD Candidate, Pathology, Royal Veteri-
nary College, London, UK
Katrina Stewart, Resident Medicine, Purdue University, 
Lafayette, IN
Jakob Trimpert, PhD Candidate, Virology, Freie Univer-
sität, Berlin, Germany
Sarah van Rijn, Intern, Resident in Small Animal Surgery, 
Utrecht University, the Netherlands.
Hans Winkler, PhD Candidate, Pharmacology, University 
of Zurich, Switzerland
Bing Yun Zhu, Resident, Small Animal Medicine, Univer-
sity of California, Davis, CA
2010
Mirjam Brackhan, Phd Candidate, Pharmacology, Tierärz-
tliche Hochschule, Hannover, Germany 
Heike Breuer, PhD Candidate, Pharmacology, Tierärztli-
che Hochschule, Hannover, Germany 
Zachary Chillag, Captain, U.S. Army Veterinary Corp., Fort 
Bragg, NC
Clinton Doering, Resident, Comparative Veterinary Oph-
thalmology, University of Calgary, Calgary, Alb
Line Greve, PhD Candidate, Sports Medicine, Royal Vet-
erinary College, London, UK
Sarah Hooper, Resident, Laboratory Animal Medicine, 
University of Missouri, Columbia, MI
Brina Lopez, PhD Candidate, Equine Medicine, University 
of Georgia, Athens, GA
Luise Steltzer-Seeker, PhD Candidate, Cell Biology, Scot-
tish Agricultural College, Edinburgh, UK
Eliza Smith, Researcher, Food Safety and zoonoses, In-
ternational Livestock Research Institute, Nairobi, Kenya,
Daniel Woodburn, Resident, Zoological Pathology, Univer-
sity of Illinois, Urbana, IL
Sirima Yaemsiri, Resident, Small Animal Medicine, Uni-
versity of California, Davis, CA
2011
Ángel Abuelo Sebio, PhD Candidate, Metabolism, Univer-
sity of Santiago de Compostela, Spain 
Jessica Brown Beck, Resident, Pathology, Purdue Univer-
sity, Lafayette, IN
Kristin Elfers, PhD Candidate, Physiology, Tierärztliche 
Hochschule, Hannover, Germany 
Per Karlsson, PhD Candidate, Robotics, Imperial College, 
University of London, UK
Maureen O’Brien, Resident, Pathology, Texas A&M Uni-
versity, College Station, TX
Erasmus zu Ermgassen, PhD Candidate, Environmental 
Science, University of Cambridge, UK
2012
Josep Duato-Botam, DPhil Candidate, Molecular Biology, 
University of Oxford, UK
Hilary Hu, PhD Candidate, Neurolbiology, Iowa State 
University, Ames, IA
Lucas Smolders, Intern, Surgery, University of Zurich, 
Switzerland
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What Did They Say?
“20 years ago I worked with 
Colin Parrish as a student. Now 
we are collaborators. Isn’t sci-
ence exciting.”
Alan Radford, 1991
“It was for sure one of the best 
things I ever did for my career 
and it truly opened the world 
to me.”
Jolanda Verhoef, 2009
“The program provided me 
with the necessary knowledge 
and motivation to pursue a 
career, both as a veterinary 
clinician and researcher, all in 
order to advance both human 
and veterinary medicine.”
Lucas Smolders, 2012 
“The 2000 Leadership Program 
propelled me along the career 
path I am now pursuing.”
Stephen Daley, 2000
“I still love to look back to that 
great summer and the valu-
able experiences I gained.”
Eva-Maria Laabs, 2006
“I have fond memories of my 
experience in the Leadership 
Program.”
Lisa Rose, 2002
“The Leadership Program was 
tremendous and another of 
the many great opportunities 
and treasured memories at 
Cornell!”
Prema Arasu, 1991
“Last February, my Professor 
from Cornell Ton Schat, stayed 
in Amsterdam. We had a very 
good conversation and shared 
great memories of the summer 
15 years ago in Ithaca.”
Anne Marije Sparnaaij, 1998
“I miss Ithaca, Cornell and 
especially the Leadership 
Program.”
Maria Volkmann, 2007 
“To this day, I am glad that I 
took part in the Leadership 
Program.”
Karyn Havas, 2002
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I attended the Cornell Leadership Program in 2001 when 
I was completing my fi nal year of veterinary school at 
the University of Queensland, Australia.  I knew at that 
time that I wanted to pursue a career in biomedical 
research, but it was the Leadership Program that 
provided me with the knowledge needed to best achieve 
this goal.  After graduating and then completing a small 
animal medicine internship at Queensland Veterinary 
Specialists, I returned to Cornell in 2003 with a Fulbright 
scholarship to pursue a Ph.D.  I completed this in 2006 
under the supervision of Dr. David Russell studying the 
host-pathogen interface in tuberculosis.  Mycobacterium 
tuberculosis parasitizes the macrophage, and my thesis 
focused on how sub-cellular compartments within the 
macrophage are manipulated by this bacterium, enabling 
it to perpetuate its own survival. I continued this line of 
investigation during my post-doctoral fellowship with Dr. 
Russell with greater focus on the bacterial components 
involved in this interaction.  In 2008, I started on faculty at the University of Calgary, Canada, as an assistant 
professor with a joint appointment to the Department of Comparative Biology and Experimental Medicine in the 
Faculty of Veterinary Medicine and the Department of Biochemistry and Molecular Biology in the Faculty of Medicine. 
The cross-appointment has been key to establishing a rigorous research program in human medicine as well as 
maintaining ties to my veterinary roots.  
 
The research team that I currently lead consists of a stellar group of nine highly-trained scientists and graduate 
students (www.ucalgary.ca/yateslab).  Together we conduct research to better understand the fundamental function 
of immune cells called phagocytes in health and disease.  These cells exist within every cubic millimeter of every 
tissue of every animal and human.  Normally they act to maintain health and guard against infection, but in certain 
people, these cells can dysfunction, leading to the destruction of healthy cells, which results in diseases such as 
multiple sclerosis (MS).  MS is the most common debilitating neurological disease that affects young-adults in the 
U.S., U.K. and Canada.  My research team is dedicated to better understand changes to antigen processing in MS, 
and other similar autoimmune disorders.  
 
In addition to biomedical research, I still get much satisfaction in teaching immunology and investigative medicine 
to DVM students in Canada’s newest veterinary college. It’s also gratifying to see some of my students be admitted 
into the Cornell Leadership Program and have them come back buzzing from the experience.  The Cornell Leadership 
Program was exceedingly infl uential on my career.  It is great to see the diversity of the leadership students, and 
career paths that this program fosters, and I feel honored to be part of its legacy.
In the Limelight: 
              Robin Yates
Robin is an Associate Professor at the University of Calgary.
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For more information about the Leadership Program, contact
John S. L. Parker
Leadership Program for Veterinary Students
Baker Institute for Animal Health
College of Veterinary Medicine
Cornell University
Ithaca, NY 14853
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